Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Danielle Brill is an analyst at Raymond James. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/10/2024 | QURE | Buy Now | uniQure | $14.36 | 262.12% | Danielle Brill43% | $20 ā $52 | Upgrade | Outperform ā Strong Buy | Get Alert |
| 11/20/2024 | TECX | Buy Now | Tectonic Therapeutic | $21.22 | 206.31% | Danielle Brill43% | ā $65 | Initiates | ā Outperform | Get Alert |
| 10/10/2024 | DNLI | Buy Now | Denali Therapeutics | $14.58 | ā | Danielle Brill43% | ā | Reinstates | ā Market Perform | Get Alert |
| 10/10/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.48 | 10.52% | Danielle Brill43% | ā $79 | Reinstates | ā Outperform | Get Alert |
| 10/10/2024 | RGNX | Buy Now | Regenxbio | $8.20 | 119.51% | Danielle Brill43% | ā $18 | Reinstates | ā Outperform | Get Alert |
| 10/10/2024 | NBIX | Buy Now | Neurocrine Biosciences | $116.50 | 33.05% | Danielle Brill43% | ā $155 | Reinstates | ā Outperform | Get Alert |
| 10/10/2024 | QURE | Buy Now | uniQure | $14.36 | 39.28% | Danielle Brill43% | ā $20 | Reinstates | ā Outperform | Get Alert |
| 10/10/2024 | IMVT | Buy Now | Immunovant | $18.25 | 97.26% | Danielle Brill43% | ā $36 | Reinstates | ā Outperform | Get Alert |
| 10/10/2024 | HRMY | Buy Now | Harmony Biosciences | $32.99 | 21.25% | Danielle Brill43% | ā $40 | Reinstates | ā Outperform | Get Alert |
| 10/10/2024 | SRPT | Buy Now | Sarepta Therapeutics | $74.15 | 102.29% | Danielle Brill43% | ā $150 | Reinstates | ā Outperform | Get Alert |
| 10/10/2024 | BIIB | Buy Now | Biogen | $139.16 | ā | Danielle Brill43% | ā | Reinstates | ā Market Perform | Get Alert |
| 10/10/2024 | SAGE | Buy Now | Sage Therapeutics | $8.75 | ā | Danielle Brill43% | ā | Reinstates | ā Market Perform | Get Alert |
| 10/10/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | ā | Danielle Brill43% | ā | Reinstates | ā Market Perform | Get Alert |
| 10/10/2024 | ARGX | Buy Now | argenx | $605.52 | -0.09% | Danielle Brill43% | ā $605 | Reinstates | ā Strong Buy | Get Alert |
| 10/10/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.11 | ā | Danielle Brill43% | ā | Reinstates | ā Market Perform | Get Alert |
| 10/10/2024 | XENE | Buy Now | Xenon Pharmaceuticals | $34.90 | 43.27% | Danielle Brill43% | ā $50 | Reinstates | ā Outperform | Get Alert |
| 10/10/2024 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | 67.21% | Danielle Brill43% | ā $51 | Reinstates | ā Outperform | Get Alert |
| 05/10/2024 | IRON | Buy Now | Disc Medicine | $52.79 | -18.55% | Danielle Brill43% | $40 ā $43 | Maintains | Outperform | Get Alert |
| 04/01/2024 | IRON | Buy Now | Disc Medicine | $52.79 | -24.23% | Danielle Brill43% | $75 ā $40 | Downgrade | Strong Buy ā Outperform | Get Alert |
| 12/21/2023 | ARGX | Buy Now | argenx | $605.52 | -14.12% | Danielle Brill43% | $580 ā $520 | Maintains | Strong Buy | Get Alert |
| 12/07/2023 | BIIB | Buy Now | Biogen | $139.16 | 103.36% | Danielle Brill43% | ā $283 | Upgrade | Market Perform ā Outperform | Get Alert |
| 11/29/2023 | ARGX | Buy Now | argenx | $605.52 | -4.21% | Danielle Brill43% | $600 ā $580 | Maintains | Strong Buy | Get Alert |
| 11/14/2023 | PASG | Buy Now | Passage Bio | $0.47 | 969.75% | Danielle Brill43% | $9 ā $5 | Maintains | Outperform | Get Alert |
| 11/01/2023 | NBIX | Buy Now | Neurocrine Biosciences | $116.50 | 24.46% | Danielle Brill43% | $135 ā $145 | Maintains | Outperform | Get Alert |
| 11/01/2023 | HRMY | Buy Now | Harmony Biosciences | $32.99 | -18.16% | Danielle Brill43% | $26 ā $27 | Maintains | Outperform | Get Alert |
| 10/16/2023 | HRMY | Buy Now | Harmony Biosciences | $32.99 | -21.19% | Danielle Brill43% | $58 ā $26 | Maintains | Outperform | Get Alert |
| 09/27/2023 | IMVT | Buy Now | Immunovant | $18.25 | 119.18% | Danielle Brill43% | ā $40 | Upgrade | Market Perform ā Outperform | Get Alert |
| 09/18/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | ā | Danielle Brill43% | ā | Downgrade | Outperform ā Underperform | Get Alert |
| 09/15/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | ā | Danielle Brill43% | ā | Downgrade | Outperform ā Underperform | Get Alert |
| 08/04/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | -2.26% | Danielle Brill43% | $58 ā $55 | Maintains | Outperform | Get Alert |
| 08/02/2023 | QURE | Buy Now | uniQure | $14.36 | 248.19% | Danielle Brill43% | $56 ā $50 | Maintains | Outperform | Get Alert |
| 08/02/2023 | HRMY | Buy Now | Harmony Biosciences | $32.99 | 75.81% | Danielle Brill43% | $62 ā $58 | Maintains | Outperform | Get Alert |
| 07/18/2023 | ARGX | Buy Now | argenx | $605.52 | -0.91% | Danielle Brill43% | $460 ā $600 | Maintains | Strong Buy | Get Alert |
| 06/27/2023 | FGEN | Buy Now | FibroGen | $0.35 | ā | Danielle Brill43% | ā | Downgrade | Outperform ā Market Perform | Get Alert |
| 06/26/2023 | FGEN | Buy Now | FibroGen | $0.35 | ā | Danielle Brill43% | ā | Downgrade | Outperform ā Market Perform | Get Alert |
| 06/12/2023 | IRON | Buy Now | Disc Medicine | $52.79 | 42.07% | Danielle Brill43% | $50 ā $75 | Upgrade | Outperform ā Strong Buy | Get Alert |
| 06/09/2023 | IRON | Buy Now | Disc Medicine | $52.79 | 42.07% | Danielle Brill43% | $50 ā $75 | Upgrade | Outperform ā Strong Buy | Get Alert |
| 05/17/2023 | IRON | Buy Now | Disc Medicine | $52.79 | -5.29% | Danielle Brill43% | ā $50 | Initiates | ā Outperform | Get Alert |
| 05/16/2023 | QURE | Buy Now | uniQure | $14.36 | 289.97% | Danielle Brill43% | $58 ā $56 | Maintains | Outperform | Get Alert |
| 05/12/2023 | PASG | Buy Now | Passage Bio | $0.47 | 1825.55% | Danielle Brill43% | $10 ā $9 | Maintains | Outperform | Get Alert |
| 05/05/2023 | ARGX | Buy Now | argenx | $605.52 | -24.03% | Danielle Brill43% | $455 ā $460 | Maintains | Strong Buy | Get Alert |
| 05/01/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | 3.07% | Danielle Brill43% | $55 ā $58 | Maintains | Outperform | Get Alert |
| 02/23/2023 | PTCT | Buy Now | PTC Therapeutics | $56.27 | -2.26% | Danielle Brill43% | $60 ā $55 | Maintains | Outperform | Get Alert |
| 01/26/2023 | FGEN | Buy Now | FibroGen | $0.35 | 9943.04% | Danielle Brill43% | ā $35 | Upgrade | Market Perform ā Outperform | Get Alert |
| 11/03/2022 | NBIX | Buy Now | Neurocrine Biosciences | $116.50 | 15.88% | Danielle Brill43% | $125 ā $135 | Maintains | Outperform | Get Alert |
| 11/03/2022 | HRMY | Buy Now | Harmony Biosciences | $32.99 | 87.94% | Danielle Brill43% | $60 ā $62 | Maintains | Outperform | Get Alert |
| 10/19/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $34.90 | 49% | Danielle Brill43% | ā $52 | Initiates | ā Outperform | Get Alert |
| 08/11/2022 | PTCT | Buy Now | PTC Therapeutics | $56.27 | 6.63% | Danielle Brill43% | $55 ā $60 | Maintains | Outperform | Get Alert |
| 08/03/2022 | HRMY | Buy Now | Harmony Biosciences | $32.99 | 81.87% | Danielle Brill43% | $58 ā $60 | Maintains | Outperform | Get Alert |
| 05/17/2022 | PASG | Buy Now | Passage Bio | $0.47 | 2039.5% | Danielle Brill43% | $24 ā $10 | Maintains | Outperform | Get Alert |
| 03/04/2022 | PASG | Buy Now | Passage Bio | $0.47 | 5034.79% | Danielle Brill43% | $29 ā $24 | Maintains | Outperform | Get Alert |
| 12/20/2021 | ARGX | Buy Now | argenx | $605.52 | -24.86% | Danielle Brill43% | $390 ā $455 | Maintains | Strong Buy | Get Alert |
| 12/17/2021 | QURE | Buy Now | uniQure | $14.36 | 303.9% | Danielle Brill43% | $75 ā $58 | Downgrade | Strong Buy ā Outperform | Get Alert |
| 11/04/2021 | HRMY | Buy Now | Harmony Biosciences | $32.99 | 75.81% | Danielle Brill43% | ā $58 | Initiates | ā Outperform | Get Alert |
| 11/02/2021 | NBIX | Buy Now | Neurocrine Biosciences | $116.50 | 28.76% | Danielle Brill43% | $163 ā $150 | Maintains | Outperform | Get Alert |
| 10/29/2021 | PTCT | Buy Now | PTC Therapeutics | $56.27 | -2.26% | Danielle Brill43% | $70 ā $55 | Maintains | Outperform | Get Alert |
| 10/04/2021 | XLRN | Buy Now | Acceleron Pharma | ā | ā | Danielle Brill43% | ā | Downgrade | Strong Buy ā Market Perform | Get Alert |
| 08/20/2021 | FGEN | Buy Now | FibroGen | $0.35 | ā | Danielle Brill43% | ā | Upgrade | Underperform ā Market Perform | Get Alert |
| 07/01/2021 | PASG | Buy Now | Passage Bio | $0.47 | 6104.54% | Danielle Brill43% | ā $29 | Initiates | ā Outperform | Get Alert |
| 07/01/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.10 | ā | Danielle Brill43% | ā | Initiates | ā Market Perform | Get Alert |
| 07/01/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $30.50 | ā | Danielle Brill43% | ā | Initiates | ā Market Perform | Get Alert |
| 03/09/2021 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.11 | 104.56% | Danielle Brill43% | $65 ā $35 | Downgrade | Strong Buy ā Outperform | Get Alert |
| 02/03/2021 | IMVT | Buy Now | Immunovant | $18.25 | 91.78% | Danielle Brill43% | $58 ā $35 | Maintains | Outperform | Get Alert |
| 02/02/2021 | NBIX | Buy Now | Neurocrine Biosciences | $116.50 | 39.91% | Danielle Brill43% | ā $163 | Initiates | ā Outperform | Get Alert |
| 01/20/2021 | GBT | Buy Now | Global Blood Therapeutics | ā | ā | Danielle Brill43% | $75 ā $50 | Downgrade | Overweight ā Neutral | Get Alert |
| 01/19/2021 | XLRN | Buy Now | Acceleron Pharma | ā | ā | Danielle Brill43% | $155 ā $160 | Maintains | Strong Buy | Get Alert |
| 01/08/2021 | SRPT | Buy Now | Sarepta Therapeutics | $74.15 | ā | Danielle Brill43% | ā | Downgrade | Outperform ā Market Perform | Get Alert |
| 12/16/2020 | PTCT | Buy Now | PTC Therapeutics | $56.27 | 24.4% | Danielle Brill43% | $63 ā $70 | Maintains | Outperform | Get Alert |
| 11/16/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.11 | 279.89% | Danielle Brill43% | ā $65 | Upgrade | Outperform ā Strong Buy | Get Alert |
| 11/06/2020 | GBT | Buy Now | Global Blood Therapeutics | ā | ā | Danielle Brill43% | ā | Downgrade | Outperform ā Market Perform | Get Alert |
| 10/26/2020 | FGEN | Buy Now | FibroGen | $0.35 | ā | Danielle Brill43% | ā | Initiates | ā Underperform | Get Alert |
| 08/25/2020 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.11 | 279.89% | Danielle Brill43% | ā $65 | Initiates | ā Outperform | Get Alert |
| 08/25/2020 | ARGX | Buy Now | argenx | $605.52 | -57.56% | Danielle Brill43% | ā $257 | Initiates | ā Outperform | Get Alert |
| 08/25/2020 | GBT | Buy Now | Global Blood Therapeutics | ā | ā | Danielle Brill43% | ā $115 | Initiates | ā Outperform | Get Alert |
| 08/25/2020 | GWPH | Buy Now | GW Pharmaceuticals | ā | ā | Danielle Brill43% | ā | Initiates | ā Market Perform | Get Alert |
| 08/25/2020 | IMVT | Buy Now | Immunovant | $18.25 | 91.78% | Danielle Brill43% | ā $35 | Initiates | ā Outperform | Get Alert |
| 08/25/2020 | PTCT | Buy Now | PTC Therapeutics | $56.27 | 11.96% | Danielle Brill43% | ā $63 | Initiates | ā Outperform | Get Alert |
| 08/25/2020 | QURE | Buy Now | uniQure | $14.36 | 422.28% | Danielle Brill43% | ā $75 | Initiates | ā Strong Buy | Get Alert |
| 08/25/2020 | SRPT | Buy Now | Sarepta Therapeutics | $74.15 | 169.72% | Danielle Brill43% | ā $200 | Initiates | ā Outperform | Get Alert |
| 08/25/2020 | ZGNX | Buy Now | Zogenix | ā | ā | Danielle Brill43% | ā | Initiates | ā Market Perform | Get Alert |
| 01/28/2020 | XLRN | Buy Now | Acceleron Pharma | ā | ā | Danielle Brill43% | $73 ā $135 | Maintains | Overweight | Get Alert |
| 09/17/2019 | ALDR | Buy Now | Alder BioPharmaceuticals | ā | ā | Danielle Brill43% | ā | Downgrade | Buy ā Hold | Get Alert |
| 05/31/2019 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.11 | 151.32% | Danielle Brill43% | $40 ā $43 | Reiterates | ā Strong Buy | Get Alert |
| 08/06/2018 | GBT | Buy Now | Global Blood Therapeutics | ā | ā | Danielle Brill43% | ā $80 | Initiates | ā Overweight | Get Alert |
| 06/27/2018 | ALDR | Buy Now | Alder BioPharmaceuticals | ā | ā | Danielle Brill43% | ā $28 | Assumes | ā Buy | Get Alert |
| 09/21/2017 | GBT | Buy Now | Global Blood Therapeutics | ā | ā | Danielle Brill43% | ā $51 | Initiates | ā Buy | Get Alert |
| 05/16/2017 | SAGE | Buy Now | Sage Therapeutics | $8.75 | 837.11% | Danielle Brill43% | ā $82 | Initiates | ā Buy | Get Alert |
| 05/16/2017 | ALDR | Buy Now | Alder BioPharmaceuticals | ā | ā | Danielle Brill43% | ā $36 | Initiates | ā Buy | Get Alert |
